Endothelial function in obstructive sleep apnea and response to treatment

Area of Science:

• Cardiovascular Medicine
• Sleep Medicine
• Vascular Biology

Background:

• Endothelium-dependent vascular relaxation is a key indicator of cardiovascular health.
• Obstructive sleep apnea (OSA) is increasingly recognized as a risk factor for cardiovascular disease.
• Endothelial dysfunction is a potential mechanism linking OSA to atherosclerosis.

Purpose of the Study:

• To investigate endothelial function in men with obstructive sleep apnea (OSA).
• To assess the impact of nasal continuous positive airway pressure (nCPAP) treatment on endothelial function in OSA patients.
• To determine if nCPAP treatment reverses endothelial dysfunction associated with OSA.

Main Methods:

• Doppler ultrasound was used to measure endothelium-dependent flow-mediated dilation (FMD) and endothelium-independent nitroglycerin (NTG)-induced dilation.
• 28 men with moderate/severe OSA were compared to 12 healthy controls.
• OSA patients were randomized to 4 weeks of nCPAP or observation; a subset was reassessed after nCPAP withdrawal.

Main Results:

• Men with OSA exhibited significantly lower FMD compared to controls (5.3% vs. 8.3%, p < 0.001).
• nCPAP treatment significantly improved FMD in OSA patients (4.4% increase), while the observation group showed no change (-0.8%).
• nCPAP withdrawal led to a decrease in FMD, returning to baseline levels, indicating treatment dependency.

Conclusions:

• Moderate to severe OSA is associated with significant endothelial dysfunction.
• nCPAP therapy effectively reverses OSA-related endothelial dysfunction.
• The beneficial effects of nCPAP on endothelial function are dependent on continuous treatment adherence.